NCT00152503View on ClinicalTrials.gov

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

May 12, 2006

Study Completion Date

May 12, 2006

Conditions

Epilepsy, Partial

Interventions

DRUG

Seletracetam (UCB44212)

"* Pharmaceutical form: oral capsules~* Concentration: 2, 10 and 50 mg~* Route of administration: oral administration"

Trial Locations (17)

Unknown

Phoenix

Little Rock

St. Petersburg

Springfield

Wichita

Detroit

Chesterfield

Cincinnati

Columbus

Philadelphia

Nashville

Dallas

Charlottesville

Milwaukee

Edmonton

Calgary

Montreal

All Listed Sponsors

lead

UCB Pharma SA

INDUSTRY

NCT00152503 - Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam | Biotech Hunter | Biotech Hunter